Cointime

Embolx

company

About

Embolx is a medical device start-up that manufactures and sells novel embolization microcatheters to treat cancer.

  • 1 - 10

Highlights

Total Funding Amount
$2.26M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Grant
Last Funding Money Raised
$2M
Industries
Health Care,Manufacturing,Medical Device
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Embolx is a venture-backed start-up in Silicon Valley that is developing and commercializing unique catheter-based systems that enable a breakthrough in minimally invasive localized cancer therapy. Embolx devices use pressure regulation to eliminate non-target delivery and increase drug distribution in the tumor using an advanced method known as Low Pressure Embolization (LPE).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$2.26M
Embolx has raised a total of $2.26M in funding over 2 rounds. Their latest funding was raised on Apr 6, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 6, 2018 Grant $2M 1 National Institutes of Health — Detail
Jun 3, 2014 Grant $269.92K 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Embolx is funded by 2 investors. National Institutes of Health and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
National Science Foundation Yes Grant
Cointime
Содержание
компания